» Articles » PMID: 31037649

Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans

Overview
Journal Mol Neurobiol
Date 2019 May 1
PMID 31037649
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases (NDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and dementia pose one of the greatest health challenges this century. Although these NDs have been looked at as single entities, the underlying molecular mechanisms have never been collectively visualized to date. With the advent of high-throughput genomic and proteomic technologies, we now have the opportunity to visualize these diseases in a whole new perspective, which will provide a clear understanding of the primary and secondary events vital in achieving the final resolution of these diseases guiding us to new treatment strategies to possibly treat these diseases together. We created a knowledge base of all microRNAs known to be differentially expressed in various body fluids of ND patients. We then used several bioinformatic methods to understand the functional intersections and differences between AD, PD, ALS, and MS. These results provide a unique panoramic view of possible functional intersections between AD, PD, MS, and ALS at the level of microRNA and their cognate genes and pathways, along with the entities that unify and separate them. While the microRNA signatures were apparent for each ND, the unique observation in our study was that hsa-miR-30b-5p overlapped between all four NDS, and has significant functional roles described across NDs. Furthermore, our results also show the evidence of functional convergence of miRNAs which was associated with the regulation of their cognate genes represented in pathways that included fatty acid synthesis and metabolism, ECM receptor interactions, prion diseases, and several signaling pathways critical to neuron differentiation and survival, underpinning their relevance in NDs. Envisioning this group of NDs together has allowed us to propose new ways of utilizing circulating miRNAs as biomarkers  and in visualizing diverse NDs more holistically . The critical molecular insights gained through the discovery of ND-associated miRNAs, overlapping miRNAs, and the functional convergence of microRNAs on vital pathways strongly implicated in neurodegenerative processes can prove immensely valuable in the identifying new generation of biomarkers, along with the development of miRNAs into therapeutics.

Citing Articles

Nucleic Acids-Based Biomarkers for Alzheimer's Disease Diagnosis and Novel Molecules to Treat the Disease.

Bivona G, Sammataro S, Ghersi G Int J Mol Sci. 2024; 25(14).

PMID: 39063135 PMC: 11277093. DOI: 10.3390/ijms25147893.


A Systematic Review of Extracellular Matrix-Related Alterations in Parkinson's Disease.

Chapman M, Sorg B Brain Sci. 2024; 14(6).

PMID: 38928523 PMC: 11201521. DOI: 10.3390/brainsci14060522.


Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy.

Pavelka L, Rauschenberger A, Hemedan A, Ostaszewski M, Glaab E, Kruger R Brain Commun. 2024; 6(3):fcae187.

PMID: 38863572 PMC: 11166179. DOI: 10.1093/braincomms/fcae187.


Molecular Mechanisms Linking Osteoarthritis and Alzheimer's Disease: Shared Pathways, Mechanisms and Breakthrough Prospects.

Umoh I, Dos Reis H, de Oliveira A Int J Mol Sci. 2024; 25(5).

PMID: 38474288 PMC: 10931612. DOI: 10.3390/ijms25053044.


Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review.

Pogoda-Wesolowska A, Dziedzic A, Maciak K, Stpien A, Dziaduch M, Saluk J Front Mol Neurosci. 2023; 16:1210091.

PMID: 37781097 PMC: 10535108. DOI: 10.3389/fnmol.2023.1210091.


References
1.
Sanphui P, Biswas S . FoxO3a is activated and executes neuron death via Bim in response to β-amyloid. Cell Death Dis. 2013; 4:e625. PMC: 3674357. DOI: 10.1038/cddis.2013.148. View

2.
De Pietri Tonelli D, Clovis Y, Huttner W . Detection and monitoring of microRNA expression in developing mouse brain and fixed brain cryosections. Methods Mol Biol. 2013; 1092:31-42. DOI: 10.1007/978-1-60327-292-6_3. View

3.
Kacperska M, Jastrzebski K, Tomasik B, Walenczak J, Konarska-Krol M, Glabinski A . Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study. J Mol Neurosci. 2014; 56(1):154-63. PMC: 4382531. DOI: 10.1007/s12031-014-0476-3. View

4.
Vlachos I, Zagganas K, Paraskevopoulou M, Georgakilas G, Karagkouni D, Vergoulis T . DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43(W1):W460-6. PMC: 4489228. DOI: 10.1093/nar/gkv403. View

5.
Zhang X, Yang R, Hu B, Lu P, Zhou L, He Z . Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease. Front Cell Neurosci. 2017; 11:170. PMC: 5481393. DOI: 10.3389/fncel.2017.00170. View